These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33459670)

  • 21. Stem cells in severe infantile spinal muscular atrophy (SMA1).
    Cohn RD
    Neuromuscul Disord; 2012 Dec; 22(12):1106-7. PubMed ID: 23206851
    [No Abstract]   [Full Text] [Related]  

  • 22. Stem cells in severe infantile spinal muscular atrophy (SMA1).
    Finkel RS
    Neuromuscul Disord; 2012 Dec; 22(12):1105-6. PubMed ID: 23206849
    [No Abstract]   [Full Text] [Related]  

  • 23. Distal infantile spinal muscular atrophy associated with paralysis of the diaphragm: a variant of infantile spinal muscular atrophy.
    Bertini E; Gadisseux JL; Palmieri G; Ricci E; Di Capua M; Ferriere G; Lyon G
    Am J Med Genet; 1989 Jul; 33(3):328-35. PubMed ID: 2801766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disease impact on general well-being and therapeutic expectations of European Type II and Type III spinal muscular atrophy patients.
    Rouault F; Christie-Brown V; Broekgaarden R; Gusset N; Henderson D; Marczuk P; Schwersenz I; Bellis G; Cottet C
    Neuromuscul Disord; 2017 May; 27(5):428-438. PubMed ID: 28237437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Muscular dystrophy campaign sponsored workshop: recommendation for respiratory care of children with spinal muscular atrophy type II and III. 13th February 2002, London, UK.
    Manzur AY; Muntoni F; Simonds A
    Neuromuscul Disord; 2003 Feb; 13(2):184-9. PubMed ID: 12565919
    [No Abstract]   [Full Text] [Related]  

  • 26. Stem cells in severe infantile spinal muscular atrophy (SMA1).
    Carrozzi M; Amaddeo A; Biondi A; Zanus C; Monti F; Alessandro V
    Neuromuscul Disord; 2012 Nov; 22(11):1032-4. PubMed ID: 23046997
    [No Abstract]   [Full Text] [Related]  

  • 27. [A newborn child with Werdnig-Hoffmann's disease (infantile spinal muscular atrophy)].
    WILLEMSE J
    Ned Tijdschr Geneeskd; 1961 Feb; 105():243-5. PubMed ID: 13785363
    [No Abstract]   [Full Text] [Related]  

  • 28. Changing respiratory expectations with the new disease trajectory of nusinersen treated spinal muscular atrophy [SMA] type 1.
    Fitzgerald DA; Doumit M; Abel F
    Paediatr Respir Rev; 2018 Sep; 28():11-17. PubMed ID: 30414815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Raising obstetricians' awareness of spinal muscular atrophy: towards early detection and reproductive planning.
    Parra J; Tizzano EF
    J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2555-8. PubMed ID: 22712688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Revised Recommendations for the Treatment of Infants Diagnosed with Spinal Muscular Atrophy Via Newborn Screening Who Have 4 Copies of SMN2.
    Glascock J; Sampson J; Connolly AM; Darras BT; Day JW; Finkel R; Howell RR; Klinger KW; Kuntz N; Prior T; Shieh PB; Crawford TO; Kerr D; Jarecki J
    J Neuromuscul Dis; 2020; 7(2):97-100. PubMed ID: 32007960
    [No Abstract]   [Full Text] [Related]  

  • 31. Electrophysiological findings in childhood spinal muscular atrophies.
    Hausmanowa-Petrusewicz I
    Rev Neurol (Paris); 1988; 144(11):716-20. PubMed ID: 3231960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trajectory of change in the swallowing status in spinal muscular atrophy type I.
    Choi YA; Suh DI; Chae JH; Shin HI
    Int J Pediatr Otorhinolaryngol; 2020 Mar; 130():109818. PubMed ID: 31945686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. State of the art for motor function assessment tools in spinal muscular atrophy (SMA).
    Vuillerot C
    Arch Pediatr; 2020 Dec; 27(7S):7S40-7S44. PubMed ID: 33357597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis and therapeutic targets in spinal muscular atrophy (SMA).
    Lefebvre S; Sarret C
    Arch Pediatr; 2020 Dec; 27(7S):7S3-7S8. PubMed ID: 33357595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spinal muscular atrophy with respiratory distress type 1 (SMARD1).
    Kaindl AM; Guenther UP; Rudnik-Schöneborn S; Varon R; Zerres K; Schuelke M; Hübner C; von Au K
    J Child Neurol; 2008 Feb; 23(2):199-204. PubMed ID: 18263757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoamine metabolites in the cerebrospinal fluid in infantile spinal muscular atrophy.
    Takeuchi Y; Komatsu H; Matsuo S; Hirai K; Kawase S; Nishimura A; Sawada T
    Neuroreport; 1994 Apr; 5(8):898-900. PubMed ID: 8061291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy and rehabilitation of the floppy infant.
    Eng GD
    R I Med J (1976); 1989 Oct; 72(10):367-70. PubMed ID: 2595191
    [No Abstract]   [Full Text] [Related]  

  • 38. Prenatal activity of a fetus with early-onset, severe spinal muscular atrophy.
    Kirkinen P; Ryynänen M; Haring P; Torkkeli H; Pääkkönen L; Martikainen A
    Prenat Diagn; 1994 Nov; 14(11):1074-6. PubMed ID: 7877956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spinal muscular atrophy.
    Iannaccone ST
    Semin Neurol; 1998; 18(1):19-26. PubMed ID: 9562664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Global management of infantile spinal muscular atrophy. Practical guide for medical staff].
    Delmas MC; Bérard C
    Pediatrie; 1990; 45(7-8):457-64. PubMed ID: 2170920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.